Exelixis EXEL

$ 41.42 0.36%

Annual report 2026
added 02-10-2026

Exelixis Total Inventories 2011-2026 | EXEL

Annual Total Inventories Exelixis

2026	2025	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
21.7 M	22.4 M	17.3 M	33.3 M	27.5 M	12.9 M	-	9.84 M	6.66 M	3.34 M	2.62 M	2.38 M	2.89 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
33.3 M	2.38 M	13.6 M

Quarterly Total Inventories Exelixis

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
27.4 M	23.5 M	24.9 M	22.4 M	21 M	20.6 M	21.1 M	17.3 M	25 M	28.6 M	29.9 M	33.3 M	26.7 M	33 M	28.5 M	27.5 M	28.2 M	25 M	24.8 M	12.9 M	19.3 M	16.6 M	15.4 M	-	13.4 M	12.4 M	10.1 M	9.84 M	9.84 M	9.84 M	9.84 M	6.66 M	6.66 M	6.66 M	6.66 M	3.34 M	3.29 M	3.34 M	3.34 M	2.62 M	2.62 M	2.62 M	2.62 M	2.38 M	2.38 M	2.38 M	2.38 M	2.89 M	2.89 M	2.89 M	2.89 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
33.3 M	2.38 M	14 M

Total Inventories of other stocks in the Biotechnology industry

	Issuer	Total Inventories	Price	% 24h	Market Cap	Country
	Amgen AMGN	6.22 B	$ 350.17	0.68 %	$ 188 B	USA
	Amphastar Pharmaceuticals AMPH	177 M	$ 19.57	0.36 %	$ 915 M	USA
	Autolus Therapeutics plc AUTL	4.14 M	$ 1.4	1.82 %	$ 357 M	Britain
	Aytu BioScience AYTU	11.4 M	$ 2.64	1.15 %	$ 16.6 M	USA
	Acorda Therapeutics ACOR	16.2 M	-	-24.86 %	$ 820 K	USA
	Albireo Pharma ALBO	194 K	-	-0.23 %	$ 916 M	USA
	Coherus BioSciences CHRS	3.17 M	$ 1.58	3.62 %	$ 185 M	USA
	BioDelivery Sciences International BDSI	23.7 M	-	-4.8 %	$ 255 M	USA
	BeiGene, Ltd. BGNE	608 M	-	0.49 %	$ 251 B	Cayman-islands
	Cara Therapeutics CARA	2.82 M	-	-3.03 %	$ 260 M	USA
	ChemoCentryx CCXI	851 K	-	-	$ 3.74 B	USA
	CorMedix CRMD	29.7 M	$ 6.29	0.64 %	$ 453 K	USA
	Clovis Oncology CLVS	13.7 M	-	-7.23 %	$ 13 M	USA